BioHarvest Sciences Inc.
BHST
$9.25
$0.303.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.33% | 8.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.33% | 8.00% | |||
| Cost of Revenue | 5.02% | 3.49% | |||
| Gross Profit | 10.69% | 11.45% | |||
| SG&A Expenses | 9.77% | 14.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.84% | 6.85% | |||
| Operating Income | -5.58% | -1.90% | |||
| Income Before Tax | -75.70% | 21.98% | |||
| Income Tax Expenses | 2.63% | 375.00% | |||
| Earnings from Continuing Operations | -74.51% | 20.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -74.51% | 20.91% | |||
| EBIT | -5.58% | -1.90% | |||
| EBITDA | -6.67% | 16.15% | |||
| EPS Basic | -74.57% | 20.88% | |||
| Normalized Basic EPS | -75.66% | 21.92% | |||
| EPS Diluted | -74.57% | 20.88% | |||
| Normalized Diluted EPS | -75.66% | 21.92% | |||
| Average Basic Shares Outstanding | 0.00% | -0.05% | |||
| Average Diluted Shares Outstanding | 0.00% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||